Skip to content

Categories

TECO®Fast Aspergillus IgG Antibody Lateral Flow Assay 

Key Features

For rapid diagnosis of chronic cavitary pulmonary aspergillosis (CCPA) and allergic bronchopulmonary aspergillosis (ABPA).

Product Description


  • Lateral flow assay in combination with fluorescence detection.
  • Validated for serum and BAL samples,
  • Simple sample preparation and 20 minutes incubation on test cassette.
  • Automatic measurement on immunofluorescence reader with calculation of index values.
  • Flexible workflow with and without incubation on board.
  • Transmission of results to internal printer, Excel file and LIS system.
  • > 93% coincidence with established ELISA tests.

Request Quotation

Product
SKU
Pack Size
Qty
TECO®Fast Aspergillus IgG Antibody Lateral Flow Assay
SKU
TE1070
Pack Size
96 tests

Request Documentation

TECO®Fast Aspergillus IgG Antibody Lateral Flow Assay
TE1070

Associated Products

Product
Immunofluorescent Analyzer for TECO Fungiline Lateral Flow Assays

Immunofluorescent Analyzer for TECO Fungiline Lateral Flow Assays

SKU : FIC-Q100N

 		TECOmedical View
Eurobio Scientific

Aspergillus Galactomannan IgG Rapid Controls (4-5 runs)

SKU : TE1080

 		TECO Medical View

Latest News

The 2024 Emissions Report
The 2024 Emissions Report

As part of our commitment to sustainability, we partner with DHL to cut transport related emissions. Details available in our new 2024 Emissions Report!

click here for more >
New Brand to reflect growth, innovation, and a unified vision to become a leading global Specialty Diagnostics company
New Brand to reflect growth, innovation, and a unified vision to become a leading global Specialty Diagnostics company

We are happy to announce that Eurobio Scientific UK will undertake a brand update to align with the evolving structure of the Eurobio Scientific Group.

This new brand embodies the collective strengths of all our affiliates, combining expertise and resources to create synergies to enhance our product offerings.

click here for more >
Navigating ER+ HER2- Early Breast Cancer
Navigating ER+ HER2- Early Breast Cancer

November 19, 2024 - Join us for the first seminar in our new series!

“Navigating ER+ HER2- Early Breast Cancer”

The session “What's new for high-risk early breast cancer patients” will focus on CDK4/6 inhibitors in the adjuvant setting for high-risk breast cancer patients, featuring a real-life case discussion and insights into the potential role of gene expression tests, including prospective validation data in high- risk patients (UNIRAD).

click here for more >
New Distribution Partnership with UTAK for Toxicology Quality Control Solutions
New Distribution Partnership with UTAK for Toxicology Quality Control Solutions

Eurobio Scientific UK is thrilled to announce its new partnership with UTAK, an esteemed American company specialising in Toxicology quality control solutions.

click here for more >

Contact Us